← Leaderboards
Virgil W Brown
Emory University
$1,942,901
Attributed
$1,942,901
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,942,901 · 2
By mechanism
R01$1,920,000 · 1
M01$22,901 · 1
Top collaborators
No co-investigators on record.
Most similar at Emory University
Same institution · by research overlap
- Stefan G Sarafianos$26,943,765
- Lily Yang$15,527,458
- Sampath Parthasarathy$11,379,014
- Hui Mao$16,442,940
- Thomas Spurgeon Wingo$12,227,212
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchLongitudinal Human StudyDrug Adverse EffectHuman SubjectProtease InhibitorAids TherapyAntiaids AgentBiomarkerBlood Lipoprotein MetabolismHyperlipidemiaLow Density Lipoprotein ReceptorOxidative StressRetinoid Binding ProteinsThiazolesRetinoidsHiv InfectionsApolipoproteinsHypertriglyceridemiaCombination Therapy
Grant awards (6)
PROTEASE INHIBITOR-INDUCED HYPERLIPIDEMIA IN AIDS$384,000
R01 · FY2004 · HL
PROTEASE INHIBITOR-INDUCED HYPERLIPIDEMIA IN AIDS$22,901
M01 · FY2004 · RR
PROTEASE INHIBITOR-INDUCED HYPERLIPIDEMIA IN AIDS$384,000
R01 · FY2003 · HL
PROTEASE INHIBITOR-INDUCED HYPERLIPIDEMIA IN AIDS$384,000
R01 · FY2002 · HL
PROTEASE INHIBITOR-INDUCED HYPERLIPIDEMIA IN AIDS$384,000
R01 · FY2001 · HL
PROTEASE INHIBITOR-INDUCED HYPERLIPIDEMIA IN AIDS$384,000
R01 · FY2000 · HL